Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Study Classification
OBSERVATIONAL
Study Start Date
1984-04-30
Study Completion Date
1996-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Originally, to determine whether genetic alterations in pathways of sodium ion transport in the red blood cells of children could predict their risk of developing primary hypertension in adulthood. In 1992, the objective was to determine the genetic basis of interindividual variation in the risk of essential hypertension in the population at large using the Rochester Family Heart Study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Family Blood Pressure Program - GenNet Network
NCT00005268
Cardiovascular Diseases
Heart Diseases
Hypertension
COMPLETED
Segregation/Linkage Analysis for Hypertension
NCT00005158
Cardiovascular Diseases
Heart Diseases
Hypertension
COMPLETED
Genetic Epidemiology of CVD Risk Factors
NCT00053521
Cardiovascular Diseases
Heart Diseases
COMPLETED
HYPGENE-Genetics Fitness Obesity & Risk of Hypertension
NCT00083811
Cardiovascular Diseases
Heart Diseases
Hypertension
+1 more
COMPLETED
Genetic Epidemiology--Development of Cardiovascular Risk
NCT00005512
Cardiovascular Diseases
Hypertension
Obesity
+1 more
COMPLETED
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
BACKGROUND:
Blood pressure has a continuous unimodal distribution in the general population. Individuals with levels elevated above the 80th percentile suffer from hypertension, a major cause of cardiovascular morbidity and mortality. Over 95 percent of hypertensives have no other primary disease and are said to have essential hypertension. Pedigree and twin studies indicate that genetic differences account for a large fraction of the interindividual variation in blood pressure. In 1984 when the study began, no genetic loci had yet been identified that were useful markers for essential hypertension or served as probes into the biological basis for interindividual blood pressure variability. Environmental factors also influence blood pressure; increased dietary intake of sodium chloride, in particular, elevates blood pressure and may contribute to the development of essential hypertension in some people. It was hypothesized that genetically determined alterations in the metabolism of sodium ion occur in a subset of the population that is at increased liability to develop elevated blood pressure upon exposure to the usual range of dietary sodium intake
Reports of altered sodium transport in the red blood cells of individuals with essential hypertension and their offspring stimulated interest in this hypothesis. Several proposals were offered to explain how alterations in sodium transport similar to those observed in red blood cells could lead to elevated blood pressure when present in the renal tubules or vascular smooth muscle. Studies of the sodium-lithium countertransport system indicated that red blood cell sodium transport pathways may provide informative phenotypes that relate blood pressure and essential hypertension more closely with genetic factors.
Numerous laboratories have confirmed that the maximal rate of sodium-lithium countertransport is increased in red blood cells from individuals with essential hypertension. The sodium-lithium countertransport is normal in secondary forms of hypertension and increased levels in essential hypertension cannot be attributed to age, body size, gender or dietary salt intake. The highest levels are observed in individuals with a positive family history of essential hypertension and the lowest levels occur in normotensive controls without hypertensive relatives.
DESIGN NARRATIVE:
When the study began in 1984, the objective was to determine whether genetic alterations in pathways of sodium transport in the red blood cells of children could predict their risk of developing primary hypertension in adulthood. Approximately 600 children between 7 and 18 years of age were randomly selected as index cases for family studies. Each participating member of the pedigrees studied underwent venipuncture for withdrawal of whole blood. A medical history was obtained from each family member visiting the clinic and a physical examination was conducted. Existing medical records for all living and deceased adult relatives in the 600 pedigrees were reviewed. In addition, 40 normotensive adult members of 300 pedigrees underwent metabolic balance and renal clearance studies, as well as ambulatory blood pressure recordings. Segregation analysis of pedigree data was carried out to determine the most likely mode for genetic transmission of the sodium-lithium counter-transport phenotype. Baseline genetic information about sodium-lithium was related to the prevalence of primary hypertension in the families of index children. Additional phenotypes involved in blood pressure regulation were also studied including renal proximal tubular sodium reabsorption, atrial natriuretic peptide, sodium-potassium adenosinetriphosphate pump, and sodium-potassium cotransport.
The study was renewed several times, the last in 1992 to continue work on the genetic basis of interindividual variation in risk of essential hypertension in the population at large using the Rochester Family Heart Study (RFHS). The RFHS was used to address three major questions: 1) Which intermediate biochemical, physiological, and anthropomorphic traits predicted blood pressure and contributed to the pathogenesis of essential hypertension 2) Did allelic variation in one or more genes have large effects on any of these intermediate traits? 3) Did information about allelic variation improve prediction of risk of essential hypertension beyond what was provided by measure of the intermediate traits?
The study completion date listed in this record was obtained from the "End Date" entered in the Protocol Registration and Results System (PRS) record.
Blood pressure has a continuous unimodal distribution in the general population. Individuals with levels elevated above the 80th percentile suffer from hypertension, a major cause of cardiovascular morbidity and mortality. Over 95 percent of hypertensives have no other primary disease and are said to have essential hypertension. Pedigree and twin studies indicate that genetic differences account for a large fraction of the interindividual variation in blood pressure. In 1984 when the study began, no genetic loci had yet been identified that were useful markers for essential hypertension or served as probes into the biological basis for interindividual blood pressure variability. Environmental factors also influence blood pressure; increased dietary intake of sodium chloride, in particular, elevates blood pressure and may contribute to the development of essential hypertension in some people. It was hypothesized that genetically determined alterations in the metabolism of sodium ion occur in a subset of the population that is at increased liability to develop elevated blood pressure upon exposure to the usual range of dietary sodium intake
Reports of altered sodium transport in the red blood cells of individuals with essential hypertension and their offspring stimulated interest in this hypothesis. Several proposals were offered to explain how alterations in sodium transport similar to those observed in red blood cells could lead to elevated blood pressure when present in the renal tubules or vascular smooth muscle. Studies of the sodium-lithium countertransport system indicated that red blood cell sodium transport pathways may provide informative phenotypes that relate blood pressure and essential hypertension more closely with genetic factors.
Numerous laboratories have confirmed that the maximal rate of sodium-lithium countertransport is increased in red blood cells from individuals with essential hypertension. The sodium-lithium countertransport is normal in secondary forms of hypertension and increased levels in essential hypertension cannot be attributed to age, body size, gender or dietary salt intake. The highest levels are observed in individuals with a positive family history of essential hypertension and the lowest levels occur in normotensive controls without hypertensive relatives.
DESIGN NARRATIVE:
When the study began in 1984, the objective was to determine whether genetic alterations in pathways of sodium transport in the red blood cells of children could predict their risk of developing primary hypertension in adulthood. Approximately 600 children between 7 and 18 years of age were randomly selected as index cases for family studies. Each participating member of the pedigrees studied underwent venipuncture for withdrawal of whole blood. A medical history was obtained from each family member visiting the clinic and a physical examination was conducted. Existing medical records for all living and deceased adult relatives in the 600 pedigrees were reviewed. In addition, 40 normotensive adult members of 300 pedigrees underwent metabolic balance and renal clearance studies, as well as ambulatory blood pressure recordings. Segregation analysis of pedigree data was carried out to determine the most likely mode for genetic transmission of the sodium-lithium counter-transport phenotype. Baseline genetic information about sodium-lithium was related to the prevalence of primary hypertension in the families of index children. Additional phenotypes involved in blood pressure regulation were also studied including renal proximal tubular sodium reabsorption, atrial natriuretic peptide, sodium-potassium adenosinetriphosphate pump, and sodium-potassium cotransport.
The study was renewed several times, the last in 1992 to continue work on the genetic basis of interindividual variation in risk of essential hypertension in the population at large using the Rochester Family Heart Study (RFHS). The RFHS was used to address three major questions: 1) Which intermediate biochemical, physiological, and anthropomorphic traits predicted blood pressure and contributed to the pathogenesis of essential hypertension 2) Did allelic variation in one or more genes have large effects on any of these intermediate traits? 3) Did information about allelic variation improve prediction of risk of essential hypertension beyond what was provided by measure of the intermediate traits?
The study completion date listed in this record was obtained from the "End Date" entered in the Protocol Registration and Results System (PRS) record.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Cardiovascular Diseases
Heart Diseases
Hypertension
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
No eligibility criteria
Maximum Eligible Age
100 Years
Eligible Sex
MALE
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Sponsor Role
lead
References
Explore related publications, articles, or registry entries linked to this study.
Boerwinkle E, Turner ST, Sing CF. The role of the genetics of sodium lithium countertransport in the determination of blood pressure variability in the population at large. Prog Clin Biol Res. 1984;165:479-507. No abstract available.
Reference Type
BACKGROUND
Sing CF, Boerwinkle E: The Genetics of Blood Pressure Variability: An Overview. In: Proceedings, Children's Blood Pressure: The Eighty-Eighth Ross Conference on Pediatric Research. Ross Laboratories, 1984
Reference Type
BACKGROUND
Turner ST, Fairbanks VF. Is measurement of erythrocyte Na+ influx useful for ascertainment of essential hypertension? Mayo Clin Proc. 1984 Jul;59(7):506-8. doi: 10.1016/s0025-6196(12)60442-x. No abstract available.
Reference Type
BACKGROUND
Turner ST, Johnson M, Boerwinkle E, Richelson E, Taswell HF, Sing CF. Sodium-lithium countertransport and blood pressure in healthy blood donors. Hypertension. 1985 Nov-Dec;7(6 Pt 1):955-62. doi: 10.1161/01.hyp.7.6.955.
Reference Type
BACKGROUND
Boerwinkle E, Chakraborty R, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods. Ann Hum Genet. 1986 May;50(2):181-94. doi: 10.1111/j.1469-1809.1986.tb01037.x.
Reference Type
BACKGROUND
Sing CF, Boerwinkle E, Turner ST. Genetics of primary hypertension. Clin Exp Hypertens A. 1986;8(4-5):623-51. doi: 10.3109/10641968609046580.
Reference Type
BACKGROUND
Richelson E, Snyder K, Carlson J, Johnson M, Turner S, Lumry A, Boerwinkle E, Sing CF. Lithium ion transport by erythrocytes of randomly selected blood donors and manic-depressive patients: lack of association with affective illness. Am J Psychiatry. 1986 Apr;143(4):457-62. doi: 10.1176/ajp.143.4.457.
Reference Type
BACKGROUND
Boerwinkle E, Turner ST, Weinshilboum R, Johnson M, Richelson E, Sing CF. Analysis of the distribution of erythrocyte sodium lithium countertransport in a sample representative of the general population. Genet Epidemiol. 1986;3(5):365-78. doi: 10.1002/gepi.1370030509.
Reference Type
BACKGROUND
Turner ST, Boerwinkle E, Johnson M, Richelson E, Sing CF. Sodium-lithium countertransport in ambulatory hypertensive and normotensive patients. Hypertension. 1987 Jan;9(1):24-34. doi: 10.1161/01.hyp.9.1.24.
Reference Type
BACKGROUND
Turner ST, Weidman WH, Michels VV, Reed TJ, Ormson CL, Fuller T, Sing CF. Distribution of sodium-lithium countertransport and blood pressure in Caucasians five to eighty-nine years of age. Hypertension. 1989 Apr;13(4):378-91. doi: 10.1161/01.hyp.13.4.378.
Reference Type
BACKGROUND
Rebbeck TR, Turner ST, Michels VV, Moll PP. Genetic and environmental explanations for the distribution of sodium-lithium countertransport in pedigrees from Rochester, MN. Am J Hum Genet. 1991 Jun;48(6):1092-104.
Reference Type
BACKGROUND
Sing CF, Haviland MB, Templeton AR, Zerba KE, Reilly SL. Biological complexity and strategies for finding DNA variations responsible for inter-individual variation in risk of a common chronic disease, coronary artery disease. Ann Med. 1992 Dec;24(6):539-47. doi: 10.3109/07853899209167008.
Reference Type
BACKGROUND
Reilly SL, Ferrell RE, Kottke BA, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants. Am J Hum Genet. 1992 Dec;51(6):1311-24.
Reference Type
BACKGROUND
Turner ST, Rebbeck TR, Sing CF. Sodium-lithium countertransport and probability of hypertension in Caucasians 47 to 89 years old. Hypertension. 1992 Dec;20(6):841-50. doi: 10.1161/01.hyp.20.6.841.
Reference Type
BACKGROUND
Schwartz GL, Turner ST, Sing CF. Twenty-four-hour blood pressure profiles in normotensive sons of hypertensive parents. Hypertension. 1992 Dec;20(6):834-40. doi: 10.1161/01.hyp.20.6.834.
Reference Type
BACKGROUND
Mailly F, Moll P, Kottke BA, Kamboh MI, Humphries SE, Ferrell RE. Estimation of the frequency of isoform-genotype discrepancies at the apolipoprotein E locus in heterozygotes for the isoforms. Genet Epidemiol. 1992;9(4):239-48. doi: 10.1002/gepi.1370090403.
Reference Type
BACKGROUND
Reilly SL, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances. Am J Hum Genet. 1991 Dec;49(6):1155-66.
Reference Type
BACKGROUND
Kottke BA, Moll PP, Michels VV, Weidman WH. Levels of lipids, lipoproteins, and apolipoproteins in a defined population. Mayo Clin Proc. 1991 Dec;66(12):1198-208. doi: 10.1016/s0025-6196(12)62470-7.
Reference Type
BACKGROUND
Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF. Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb. 1991 Sep-Oct;11(5):1330-48. doi: 10.1161/01.atv.11.5.1330.
Reference Type
BACKGROUND
Turner ST, Michels VV. Sodium-lithium countertransport and hypertension in Rochester, Minnesota. Hypertension. 1991 Aug;18(2):183-90. doi: 10.1161/01.hyp.18.2.183.
Reference Type
BACKGROUND
Perusse L, Moll PP, Sing CF. Evidence that a single gene with gender- and age-dependent effects influences systolic blood pressure determination in a population-based sample. Am J Hum Genet. 1991 Jul;49(1):94-105.
Reference Type
BACKGROUND
Reilly SL, Kottke BA, Sing CF. The effects of generation and gender on the joint distributions of lipid and apolipoprotein phenotypes in the population at large. J Clin Epidemiol. 1990;43(9):921-40. doi: 10.1016/0895-4356(90)90076-2.
Reference Type
BACKGROUND
Kwon JM, Boehnke M, Burns TL, Moll PP. Commingling and segregation analyses: comparison of results from a simulation study of a quantitative trait. Genet Epidemiol. 1990;7(1):57-68. doi: 10.1002/gepi.1370070113.
Reference Type
BACKGROUND
Zerba KE, Friedlaender JS, Sing CF. Heterogeneity of the blood pressure distribution among Solomon Islands societies with increasing acculturation. Am J Phys Anthropol. 1990 Apr;81(4):493-511. doi: 10.1002/ajpa.1330810406.
Reference Type
BACKGROUND
Rebbeck TR, Turner ST, Sing CF. Sodium-lithium countertransport genotype and the probability of hypertension in adults. Hypertension. 1993 Oct;22(4):560-8. doi: 10.1161/01.hyp.22.4.560.
Reference Type
BACKGROUND
Reilly SL, Sing CF, Savageau MA, Turner ST. Analysis of systems influencing renal hemodynamics and sodium excretion. I. Biochemical systems theory. Integr Physiol Behav Sci. 1994 Jan-Mar;29(1):55-73. doi: 10.1007/BF02691281.
Reference Type
BACKGROUND
Turner ST, Reilly SL. Renal sodium excretion in sons of hypertensive parents. Hypertension. 1993 Sep;22(3):323-30. doi: 10.1161/01.hyp.22.3.323.
Reference Type
BACKGROUND
Kardia SL, Sing CF, Turner ST. The response of renal plasma flow to angiotensin II infusion in a population-based sample and its association with the parental history of essential hypertension. J Hypertens. 1997 May;15(5):483-93. doi: 10.1097/00004872-199715050-00003.
Reference Type
BACKGROUND
Stengard JH, Zerba KE, Turner ST, Sing CF. A biometrical study of the relationship between sodium-lithium countertransport and triglycerides. Ann Hum Genet. 1997 Mar;61(Pt 2):121-36. doi: 10.1046/j.1469-1809.1997.6120121.x.
Reference Type
BACKGROUND
Turner ST, Sing CF. Erythrocyte sodium transport and the probability of having hypertension. J Hypertens. 1996 Jul;14(7):829-37. doi: 10.1097/00004872-199607000-00005.
Reference Type
BACKGROUND
Flickinger AL, Lerman LO, Sheedy PF 2nd, Turner ST. The relationship between renal cortical volume and predisposition to hypertension. Am J Hypertens. 1996 Aug;9(8):779-86. doi: 10.1016/0895-7061(96)00097-0.
Reference Type
BACKGROUND
Schwartz GL, Turner ST, Sing CF. Association of genetic variation with interindividual variation in ambulatory blood pressure. J Hypertens. 1996 Feb;14(2):251-8. doi: 10.1097/00004872-199602000-00015.
Reference Type
BACKGROUND
Rebbeck TR, Turner ST, Sing CF. Probability of having hypertension: effects of sex, history of hypertension in parents, and other risk factors. J Clin Epidemiol. 1996 Jul;49(7):727-34. doi: 10.1016/0895-4356(96)00015-7.
Reference Type
BACKGROUND
Flickinger AL, Burnett JC Jr, Turner ST. Atrial natriuretic peptide and blood pressure in a population-based sample. Mayo Clin Proc. 1995 Oct;70(10):932-8. doi: 10.4065/70.10.932.
Reference Type
BACKGROUND
Turner ST, Reilly SL. Fallacy of indexing renal and systemic hemodynamic measurements for body surface area. Am J Physiol. 1995 Apr;268(4 Pt 2):R978-88. doi: 10.1152/ajpregu.1995.268.4.R978.
Reference Type
BACKGROUND
Sing CF, Moll PP. Genetics of atherosclerosis. Annu Rev Genet. 1990;24:171-87. doi: 10.1146/annurev.ge.24.120190.001131. No abstract available.
Reference Type
BACKGROUND
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1040
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Genetic Basis of Abdominal Aortic Aneurysm
NCT00005526
COMPLETED
Genetic Epidemiology of Change in CVD Risk Factors
NCT00037440
COMPLETED
Epidemiology of Blood Pressure, Insulin, Salt Transport
NCT00005249
COMPLETED
Genetics of Hypertension in Blacks
NCT00005387
COMPLETED
Genetic Determinants of Sudden Cardiac Death
NCT00064558
COMPLETED
Family Blood Pressure Program - SAPPHIRe Network
NCT00005270
COMPLETED
Genetic Analysis of Familial Hypertrophic Cardiomyopathy
NCT00005251
COMPLETED
Genetics of Low Density Lipoprotein Subclasses in Hypercholesterolemia
NCT00005203
COMPLETED
Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia
NCT00005313
COMPLETED
Molecular Epidemiology of Essential Hypertension
NCT00005377
COMPLETED
Signs and Symptoms of Genetic Abnormalities Linked to Inherited Heart Disease
NCT00001881
COMPLETED
Genetic Epidemiology of Hypertriglyceridemia
NCT00005368
COMPLETED
Genetic Predictors of Incident Cardiovascular Disease
NCT00035672
WITHDRAWN
Family Blood Pressure Program - GENOA
NCT00005269
COMPLETED
Screening for Inherited Heart Disease
NCT00001746
COMPLETED
Characterization Of Coronary Prone Pedigrees
NCT00005139
COMPLETED
Long QT Syndrome-Population Genetics and Cardiac Studies
NCT00005176
COMPLETED
Antihypertensive Drug/Gene Interactions and CV Events
NCT00005332
COMPLETED
GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study
NCT05216042
RECRUITING
NA
Racial Variation in ACE--Genetic and Physiologic Bases
NCT00005757
COMPLETED
Rutgers University Study of the Genetics of Pulmonary Hypertension
NCT07217522
RECRUITING
Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions
NCT02691689
RECRUITING
NA
Familial Aggregation of Stress Response
NCT00005428
COMPLETED
Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African Americans Study (GENE-FORECAST): Sodium Intervention Trial (SIT)
NCT04717336
COMPLETED
NA
Genetic Epidemiology of Coronary Heart Disease
NCT00005209
COMPLETED